Aimei Health Technology Co., Ltd. is a pioneering force in the healthcare industry, focused on leveraging advanced technologies to revolutionize patient care and health management. The company excels in developing and manufacturing cutting-edge medical devices and comprehensive health management systems designed to enhance patient outcomes and streamline healthcare delivery. With a robust commitment to innovation, quality, and strategic partnerships, Aimei is strategically positioned to meet the evolving demands of the global healthcare market. Its research-centric strategy not only cultivates a diverse portfolio of transformative solutions but also ensures alignment with emerging healthcare trends, setting the stage for sustained growth and significant impact in the sector.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | -1.04% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $-0.56 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | -30.20% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $4.40M |
| % Insiders | 0.00% |
| % Institutions | 0.04% |